title: Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.
authors.forename: F
authors.initials: F
authors.lastname: Leoni
authors.forename: S
authors.initials: S
authors.lastname: Ciolli
authors.forename: C
authors.initials: C
authors.lastname: Nozzoli
authors.forename: V
authors.initials: V
authors.lastname: Santini
authors.forename: R
authors.initials: R
authors.lastname: Fanci
authors.forename: P
authors.initials: P
authors.lastname: Rossi Ferrini
mesh_terms: D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000592:standards / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000592:standards; D018572:Disease-Free Survival; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D019772:Topotecan / Q000008:administration & dosage / Q000592:standards; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000592:standards
chemical_list: D003561:Cytarabine; D019772:Topotecan; D014740:Vidarabine; C024352:fludarabine